New malaria-blocking vaccines tested in kids and adults
NCT ID NCT06549257
First seen Mar 01, 2026 · Last updated May 14, 2026 · Updated 11 times
Summary
This study tests two experimental vaccines designed to stop the spread of malaria from person to person. They are given to healthy volunteers aged 5 to 45 in Burkina Faso, where malaria is common. The goal is to check if the vaccines are safe and trigger a strong immune response.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Institut des Sciences et Techniques (INSTech)
Bobo-Dioulasso, 01 BP 2779, Burkina Faso
Conditions
Explore the condition pages connected to this study.